Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Tango Therapeutics Q4 GAAP EPS $(0.32) Misses $(0.28) Estimate, Sales $5.43M Miss $8.24M Estimate

Author: Benzinga Newsdesk | March 18, 2024 07:43am
Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.28) by 14.29 percent. This is a 3.03 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $5.43 million which missed the analyst consensus estimate of $8.24 million by 34.09 percent. This is a 15.29 percent decrease over sales of $6.41 million the same period last year.

Posted In: TNGX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist